Stock DEX DEXTECH MEDICAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Dextech Medical AB

Equities

DEX

SE0005881489

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 03:30:00 08/05/2024 am IST 		5-day change 1st Jan Change
4.98 SEK +1.63% Intraday chart for Dextech Medical AB +2.89% +26.72%
26/04 Dextech Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
15/04 DexTech Medical Announces New Positive Results from the Myeloma Study CI

Business Summary

Dextech Medical AB is a Sweden-based research company specialized in urologic oncology. It is focused on prostate cancer, but also other cancers and non-malignant diseases. It develops drug canditates based on modified carbohydrate molecule combined with active substances. The Company has a patented technology platform, GuaDex, and three drug candidates with patents or patent applications. The portfolio includes: OsteoDex, for treatment of bone metastases in castration resistant prostate cancer (CRPC); SomaDex, based on endogenous hormone, somatostatin, and aimed at treatment of acromegaly, neuroendocrine tumors and palliative treatment of CRPC; and CatDex, for instillation treatment of bladder cancer.

Number of employees: 1

Managers

Managers TitleAgeSince
Anders Ragnarson Holmberg CEO
 Chief Executive Officer 73 21/04/21
Gösta Lundgren DFI
 Director of Finance/CFO 69 01/13/01

Members of the board

Members of the board TitleAgeSince
Peter James Arthur Benson BRD
 Director/Board Member 69 -
Andreas Segerros CHM
 Chairman 63 -
Svante Wadman BRD
 Director/Board Member 71 02/06/02
Rolf Weste Eriksson BRD
 Director/Board Member 72 24/14/24
Per-Olov Asplund BRD
 Director/Board Member 75 12/13/12
Anders Ragnarson Holmberg CEO
 Chief Executive Officer 73 21/04/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,485,857 7,158,151 ( 38.72 %) 0 38.72 %

Company contact information

Dextech Medical AB

Dag Hammarskjölds Väg 34A

752 37, Uppsala

+46 7 07 10 47 88

http://www.dextechmedical.com
address Dextech Medical AB(DEX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
DEXTECH MEDICAL AB Stock Dextech Medical AB
+26.72% 8.47M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+3.25% 108B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.07% 104B
ARGENX SE Stock argenx SE
+1.25% 22.33B
BIONTECH SE Stock BioNTech SE
-11.98% 22.19B
GENMAB A/S Stock Genmab A/S
-7.05% 18.69B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.36% 17.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.05% 17.64B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.15% 14.05B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+34.39% 12.51B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. DEX Stock
  4. Company Dextech Medical AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW